Skip to Main Content

This is a test.

NEOCATS trial: Targeting the targets with a combination of three treatments

This is a test.

ES2 trial: combining a PARP inhibitor and apoptosis sensitizer

This is a test.

Phase II clinical trial of CX5461 at the time of disease progression on a PARP inhibitor

This is a test.

Re-VOLVE trial: using genomics to make treatment decisions after a PARP inhibitor

This is a test.

Developing new treatments for clear cell ovarian cancer

This is a test.

Developing optimal treatment combinations for small cell carcinoma of the ovary

This is a test.

Supercharging CAR-T cells for Ovarian Cancer

This is a test.

Development of therapeutic vaccines against ovarian cancer

This is a test.

Tumour testing and ovarian cancer drug prediction program

This is a test.

Targeting epitranscriptomic mechanisms in ovarian cancer